Moroni, Gabriella Luisa
 Distribuzione geografica
Continente #
AS - Asia 3.960
NA - Nord America 3.598
SA - Sud America 914
EU - Europa 693
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 85
OC - Oceania 7
Totale 9.503
Nazione #
US - Stati Uniti d'America 3.411
SG - Singapore 2.299
BR - Brasile 745
CN - Cina 629
VN - Vietnam 469
IT - Italia 338
HK - Hong Kong 195
CA - Canada 72
MX - Messico 72
AR - Argentina 71
GB - Regno Unito 59
IN - India 57
ID - Indonesia 44
BD - Bangladesh 42
DE - Germania 40
EC - Ecuador 34
FR - Francia 30
FI - Finlandia 27
PL - Polonia 27
IE - Irlanda 26
PK - Pakistan 23
IQ - Iraq 22
UA - Ucraina 22
TR - Turchia 21
JP - Giappone 20
MY - Malesia 20
ZA - Sudafrica 20
CO - Colombia 18
PH - Filippine 18
AT - Austria 17
ES - Italia 16
MA - Marocco 16
NL - Olanda 16
CL - Cile 14
RU - Federazione Russa 14
SE - Svezia 13
AE - Emirati Arabi Uniti 12
CR - Costa Rica 11
SA - Arabia Saudita 11
VE - Venezuela 11
EG - Egitto 10
TN - Tunisia 10
PY - Paraguay 9
TH - Thailandia 9
AL - Albania 8
AZ - Azerbaigian 8
KE - Kenya 8
JO - Giordania 7
PA - Panama 7
CH - Svizzera 6
UZ - Uzbekistan 6
BG - Bulgaria 5
KZ - Kazakistan 5
UY - Uruguay 5
ET - Etiopia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
SV - El Salvador 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
KR - Corea 3
LT - Lituania 3
NG - Nigeria 3
NI - Nicaragua 3
PE - Perù 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
Totale 9.236
Città #
Singapore 995
Ashburn 581
San Jose 570
The Dalles 447
Council Bluffs 240
Beijing 204
Hong Kong 193
Dallas 169
Ho Chi Minh City 160
Shanghai 139
Santa Clara 116
Hanoi 115
New York 107
Milan 83
Los Angeles 73
São Paulo 62
Buffalo 53
Rome 52
Boardman 46
Mexico City 45
Naples 32
Wilmington 32
Assago 28
Helsinki 27
Warsaw 27
Brooklyn 24
Dublin 24
Haiphong 22
Phoenix 21
Chandler 20
Da Nang 20
Rio de Janeiro 20
Montreal 19
Tokyo 19
Orem 17
Chicago 16
Boston 15
Fort Worth 15
Seattle 15
Belo Horizonte 14
Brasília 13
Curitiba 13
Hải Dương 13
Johannesburg 13
Biên Hòa 12
Jakarta 12
Quito 12
Charlotte 11
Kuala Lumpur 11
Stockholm 11
Vienna 11
Atlanta 10
Campinas 10
Chennai 10
Philadelphia 10
Prineville 10
Salvador 10
San Mateo 10
Can Tho 9
Hillsboro 9
Mumbai 9
San Francisco 9
Springfield 9
Toronto 9
Baghdad 8
Baku 8
Buenos Aires 8
Guayaquil 8
Nuremberg 8
Poplar 8
Queens 8
Reston 8
San José 8
Thái Bình 8
Washington 8
Amman 7
Amsterdam 7
Denver 7
Dhaka 7
London 7
Milwaukee 7
Nairobi 7
Porto Alegre 7
Saint Paul 7
Ankara 6
Asunción 6
Bắc Ninh 6
Dubai 6
Figino 6
Frankfurt am Main 6
Manchester 6
Miami 6
Pasadena 6
Santiago 6
Sorocaba 6
Wuhan 6
Bologna 5
Campos dos Goytacazes 5
Canoas 5
Castro dei Volsci 5
Totale 5.376
Nome #
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 134
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 126
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 97
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study 95
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 90
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 87
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 87
Nephrotic syndrome: pathophysiology and consequences 86
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 82
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 78
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 77
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 77
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 76
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 74
Is per-protocol kidney biopsy required in lupus nephritis? 70
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 69
ANCA-associated vasculitis in childhood: Recent advances 68
ANCA-associated vasculitis with renal involvement 66
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 65
Renal sarcoidosis 65
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 64
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 63
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy (vol 29, pg 277, 2016) 63
''Nephritic flares'' are predictors of bad long-term renal outcome in lupus nephritis 62
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 62
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 61
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 61
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up 61
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 61
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 60
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 59
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 58
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 58
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 58
Monoclonal gammopathy in lupus nephritis 57
Neutrophil Extracellular Traps in the Autoimmunity Context 57
Acid-base balance and respiratory response during biofiltration with polyacrylonitrile membrane 57
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 56
Renal replacement therapy in sarcoidosis 54
Anti-glomerular basement membrane vasculitis 53
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 53
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 53
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 52
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 52
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 52
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis 52
Anti-C1Q monitoring predicts relapses of lupus nephritis 52
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 52
Lupus nephritis: clinical presentations and outcomes in the 21st century 52
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management 51
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease 51
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 51
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 51
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review 51
Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature 50
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 50
Lupus Membranous Nephropathy 50
Anti-C1q Autoantibodies in Lupus Nephritis 50
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 49
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study 49
Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis 48
Autophagy: A Silent Protagonist in Kidney Transplantation 48
Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature 48
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 48
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 47
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 47
Treatment of membranous lupus nephritis 47
Lupus nephritis: When and how often to biopsy and what does it mean? 47
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 47
Acute renal failure in a single kidney with previous obstruction 46
Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults 46
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 46
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up 46
Alport syndrome and pregnancy: a case series and literature review 46
How We Treat Dyslipidemia in Prolonged Nephrotic Syndrome 46
Old and new calcineurin inhibitors in lupus nephritis 46
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy 45
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis 45
Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 45
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression 45
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 45
Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases 44
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 44
Is preeclampsia a risk for end-stage renal disease? 44
Pregnancy after lupus nephritis 44
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 43
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease 43
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis 43
Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides) 42
Rituximab therapy for primary glomerulonephritis: Report on two cases 42
Pregnancy in lupus nephritis 41
Laser capture microdissection on formalin-fixed and paraffin-embedded renal transplanted biopsies: Technical perspectives for clinical practice application 41
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 41
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 41
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years 41
Delayed Diagnosis of West Nile Virus Infection in a Kidney Transplant Patient Due to Inaccuracies in Commonly Available Diagnostic Tests 41
Hydroxychloroquine in systemic lupus erythematosus (SLE) 40
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 40
Lupus membranous nephropathy: long-term outcome 40
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort 40
Totale 5.646
Categoria #
all - tutte 49.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 4 2 2 1 3 0 2 4 1
2022/202371 7 2 5 7 4 4 2 4 6 5 4 21
2023/2024285 35 13 50 22 15 43 36 11 4 2 18 36
2024/20252.211 13 97 65 14 17 233 135 174 266 602 296 299
2025/20266.123 820 392 322 669 223 351 1.418 386 379 495 282 386
2026/2027753 377 376 0 0 0 0 0 0 0 0 0 0
Totale 9.503